288 related articles for article (PubMed ID: 33606602)
1. Postexposure Liponucleotide Prophylaxis and Treatment Attenuates Acute Respiratory Distress Syndrome in Influenza-infected Mice.
Rosas LE; Doolittle LM; Joseph LM; El-Musa H; Novotny MV; Hickman-Davis JM; Hite RD; Davis IC
Am J Respir Cell Mol Biol; 2021 Jun; 64(6):677-686. PubMed ID: 33606602
[TBL] [Abstract][Full Text] [Related]
2. Lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome.
Woods PS; Doolittle LM; Rosas LE; Joseph LM; Calomeni EP; Davis IC
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1160-L1169. PubMed ID: 27836900
[TBL] [Abstract][Full Text] [Related]
3. Cytidine 5'-Diphosphocholine Corrects Alveolar Type II Cell Mitochondrial Dysfunction in Influenza-infected Mice.
Doolittle LM; Binzel K; Nolan KE; Craig K; Rosas LE; Bernier MC; Joseph LM; Woods PS; Knopp MV; Davis IC
Am J Respir Cell Mol Biol; 2022 Jun; 66(6):682-693. PubMed ID: 35442170
[TBL] [Abstract][Full Text] [Related]
4. Postinfection A77-1726 treatment improves cardiopulmonary function in H1N1 influenza-infected mice.
Aeffner F; Bratasz A; Flaño E; Powell KA; Davis IC
Am J Respir Cell Mol Biol; 2012 Oct; 47(4):543-51. PubMed ID: 22679275
[TBL] [Abstract][Full Text] [Related]
5. Infection of mice with influenza A/WSN/33 (H1N1) virus alters alveolar type II cell phenotype.
Hofer CC; Woods PS; Davis IC
Am J Physiol Lung Cell Mol Physiol; 2015 Apr; 308(7):L628-38. PubMed ID: 25595651
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of microRNA-155-5p by alveolar type II cells contributes to development of lethal ARDS in H1N1 influenza A virus-infected mice.
Woods PS; Doolittle LM; Rosas LE; Nana-Sinkam SP; Tili E; Davis IC
Virology; 2020 Jun; 545():40-52. PubMed ID: 32308197
[TBL] [Abstract][Full Text] [Related]
7. Impact of cytidine diphosphocholine on oxygenation in client-owned dogs with aspiration pneumonia.
Young AA; Rosas LE; Cooper ES; Yaxley PE; Davis IC
J Vet Intern Med; 2022 May; 36(3):1089-1099. PubMed ID: 35484990
[TBL] [Abstract][Full Text] [Related]
8. SCARLET (Supplemental Citicoline Administration to Reduce Lung injury Efficacy Trial): study protocol for a single-site, double-blinded, placebo-controlled, and randomized Phase 1/2 trial of i.v. citicoline (CDP-choline) in hospitalized SARS CoV-2-infected patients with hypoxemic acute respiratory failure.
Pannu S; Exline MC; Bednash JS; Englert JA; Diaz P; Bartlett A; Brock G; Wu Q; Davis IC; Crouser ED
Trials; 2024 May; 25(1):328. PubMed ID: 38760804
[TBL] [Abstract][Full Text] [Related]
9. ATP catabolism by tissue nonspecific alkaline phosphatase contributes to development of ARDS in influenza-infected mice.
Woods PS; Doolittle LM; Hickman-Davis JM; Davis IC
Am J Physiol Lung Cell Mol Physiol; 2018 Jan; 314(1):L83-L92. PubMed ID: 28982733
[TBL] [Abstract][Full Text] [Related]
10. Activation of A1-adenosine receptors promotes leukocyte recruitment to the lung and attenuates acute lung injury in mice infected with influenza A/WSN/33 (H1N1) virus.
Aeffner F; Woods PS; Davis IC
J Virol; 2014 Sep; 88(17):10214-27. PubMed ID: 24965449
[TBL] [Abstract][Full Text] [Related]
11. Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures.
Margaroli C; Benson P; Sharma NS; Madison MC; Robison SW; Arora N; Ton K; Liang Y; Zhang L; Patel RP; Gaggar A
Cell Rep Med; 2021 Apr; 2(4):100242. PubMed ID: 33778787
[TBL] [Abstract][Full Text] [Related]
12. Acute respiratory distress syndrome induced by a swine 2009 H1N1 variant in mice.
Zhang Y; Sun H; Fan L; Ma Y; Sun Y; Pu J; Yang J; Qiao J; Ma G; Liu J
PLoS One; 2012; 7(1):e29347. PubMed ID: 22235288
[TBL] [Abstract][Full Text] [Related]
13. Alveolar type II cells and pulmonary surfactant in COVID-19 era.
Calkovska A; Kolomaznik M; Calkovsky V
Physiol Res; 2021 Dec; 70(S2):S195-S208. PubMed ID: 34913352
[TBL] [Abstract][Full Text] [Related]
14. Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 Virus.
Fukushi M; Yamashita M; Miyoshi-Akiyama T; Kubo S; Yamamoto K; Kudo K
PLoS One; 2012; 7(8):e42419. PubMed ID: 22879974
[TBL] [Abstract][Full Text] [Related]
15. Necroptosis blockade prevents lung injury in severe influenza.
Gautam A; Boyd DF; Nikhar S; Zhang T; Siokas I; Van de Velde LA; Gaevert J; Meliopoulos V; Thapa B; Rodriguez DA; Cai KQ; Yin C; Schnepf D; Beer J; DeAntoneo C; Williams RM; Shubina M; Livingston B; Zhang D; Andrake MD; Lee S; Boda R; Duddupudi AL; Crawford JC; Vogel P; Loch C; Schwemmle M; Fritz LC; Schultz-Cherry S; Green DR; Cuny GD; Thomas PG; Degterev A; Balachandran S
Nature; 2024 Apr; 628(8009):835-843. PubMed ID: 38600381
[TBL] [Abstract][Full Text] [Related]
16. Influenza A H1N1 induces declines in alveolar gas exchange in mice consistent with rapid post-infection progression from acute lung injury to ARDS.
Traylor ZP; Aeffner F; Davis IC
Influenza Other Respir Viruses; 2013 May; 7(3):472-9. PubMed ID: 22862736
[TBL] [Abstract][Full Text] [Related]
17. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis.
Narasaraju T; Yang E; Samy RP; Ng HH; Poh WP; Liew AA; Phoon MC; van Rooijen N; Chow VT
Am J Pathol; 2011 Jul; 179(1):199-210. PubMed ID: 21703402
[TBL] [Abstract][Full Text] [Related]
18. Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza: A Systematic Review.
Hariri LP; North CM; Shih AR; Israel RA; Maley JH; Villalba JA; Vinarsky V; Rubin J; Okin DA; Sclafani A; Alladina JW; Griffith JW; Gillette MA; Raz Y; Richards CJ; Wong AK; Ly A; Hung YP; Chivukula RR; Petri CR; Calhoun TF; Brenner LN; Hibbert KA; Medoff BD; Hardin CC; Stone JR; Mino-Kenudson M
Chest; 2021 Jan; 159(1):73-84. PubMed ID: 33038391
[TBL] [Abstract][Full Text] [Related]
19. Heterozygosity for the F508del mutation in the cystic fibrosis transmembrane conductance regulator anion channel attenuates influenza severity.
Aeffner F; Abdulrahman B; Hickman-Davis JM; Janssen PM; Amer A; Bedwell DM; Sorscher EJ; Davis IC
J Infect Dis; 2013 Sep; 208(5):780-9. PubMed ID: 23749967
[TBL] [Abstract][Full Text] [Related]
20. Tumor Progression Locus 2 Protects against Acute Respiratory Distress Syndrome in Influenza A Virus-Infected Mice.
Latha K; Rao S; Sakamoto K; Watford WT
Microbiol Spectr; 2022 Oct; 10(5):e0113622. PubMed ID: 35980186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
